Product information and disease descriptionProduct descriptionProduct information
Average sales price and wholesale acquisition cost
4 evidence topics · 4 sources
Announced price for azetukalner
No evidence found.
No approved product and no product revenue
Branded adjunctive antiseizure medication comparators: United States National Average Drug Acquisition Cost, week of 16 September 2026
| Product and strength | Quoted record description | Quoted acquisition cost per unit | Quoted effective date |
|---|---|---|---|
| Cenobamate 200 mg tablet | “XCOPRI 200 MG TABLET” | “39.86819” | “2026-08-19” |
| Brivaracetam 100 mg tablet | “BRIVIACT 100 MG TABLET” | “24.07624” | “2026-08-19” |
| Perampanel 12 mg tablet | “FYCOMPA 12 MG TABLET” | “39.07764” | “2026-08-19” |